Vitamin-D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients
Laurence Orchard, Matthew Baldry, Myra Nasim-Mohi, Chantelle Monck, Kordo Saeed, Michael P W Grocott, Dushianthan Ahilanandan
Clinical Chemistry and Laboratory Medicine (CCLM), doi:10.1515/cclm-2020-1567
Objectives: The pattern of global COVID-19 has caused many to propose a possible link between susceptibility, severity and vitamin-D levels. Vitamin-D has known immune modulatory effects and deficiency has been linked to increased severity of viral infections. Methods: We evaluated patients admitted with confirmed SARS-COV-2 to our hospital between March-June 2020. Demographics and outcomes were assessed for those admitted to the intensive care unit (ICU) with normal (>50 nmol/L) and low (<50 nmol/L) vitamin-D. Results: There were 646 SARS-COV-2 PCR positive hospitalisations and 165 (25.5%) had plasma vitamin-D levels. Fifty patients were admitted to ICU. There was no difference in vitamin-D levels of those hospitalised (34, IQR 18.5-66 nmol/L) and those admitted to the ICU (31.5, IQR 21-42 nmol/L). Higher proportion of vitamin-D deficiency (<50 nmol/L) noted in the ICU group (82.0 vs. 65.2%). Among the ICU patients, low vitamin D level (<50 nmol/L) was associated with younger age (57 vs. 67 years, p=0.04) and lower cycle threshold (CT) real time polymerase chain reaction values (RT-PCR) (26.96 vs. 33.6, p=0.02) analogous to higher viral loads. However, there were no significant differences in ICU clinical outcomes (invasive and non-invasive mechanical ventilation, acute kidney injury and mechanical ventilation and hospital days) between patients with low and normal vitamin-D levels. Conclusions: Despite the association of low vitamin-D levels with low CT values, there is no difference in clinical outcomes in this small cohort of critically ill COVID-19 patients. The complex relationship between vitamin-D levels and COVID-19 infection needs further exploration with large scale randomized controlled trials.
References
Adams, Ren, Liu, Chun, Lagishetty et al., Vitamin D-directed rheostatic regulation of monocyte antibacterial responses, J Immunol
Almerighi, Sinistro, Cavazza, Ciaprini, Rocchi et al., 1alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes, Cytokine
Anwar, Hamdy, Taher, Fawzy, Abdulattif et al., Burden and outcome of vitamin D deficiency among critically ill patients: a prospective study, Nutr Clin Pract
Aygun, Vitamin D can prevent COVID-19 infection-induced multiple organ damage, Naunyn-Schmiedeberg's Arch Pharmacol
Barlow, Svoboda, Mackellar, Nash, York et al., Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37, PloS One
Bates, Lennox, Prentice, Bates, Swan, National diet and nutrition survey
Chandran, Maung, Mithal, Parameswaran, Vitamin D in COVID-19: dousing the fire or averting the storm? -a perspective from the Asia-Pacific, Osteoporos Sarcopenia,
doi:10.1016/j.afos.2020.07.003
Charoenngam, Holick, Immunologic effects of vitamin D on human health and disease, Nutrients,
doi:10.3390/nu12072097
D'avolio, Avataneo, Manca, Cusato, Nicolò et al., 25-hhydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2, Nutrients,
doi:10.3390/nu12051359
Dancer, Parekh, Lax, Souza, Zheng et al., Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS), Thorax
Hastie, Mackay, Ho, Celis-Morales, Katikireddi et al., Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr
Huang, Ran, Lv, Feng, Ran et al., Chronological changes of viral shedding in adult inpatients with COVID-19 in Wuhan, China, Clin Infect Dis,
doi:10.1093/cid/ciaa631
Im, Je, Baek, Chung, Kwon et al., Nutritional status of patients with coronavirus disease 2019 (COVID-19), Int J Infect Dis,
doi:10.1016/j.ijid.2020.08.018
Kellum, Lameire, Aspelin, Barsoum, Burdmann et al., Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury, Kidney Int Suppl
Lofgren, Fefferman, Naumov, Gorski, Naumova, Influenza seasonality: underlying causes and modeling theories, J Virol
Meltzer, Best, Zhang, Vokes, Arora et al., Association of vitamin D deficiency and treatment with COVID-19 incidence, medRxiv,
doi:10.1101/2020.05.08.20095893
Merzon, Tworowski, Gorohovski, Vinker, Cohen et al., Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli populationbased study, FEBS J,
doi:10.1111/febs.15495
Mitchell, Vitamin-D and COVID-19: do deficient risk a poorer outcome?, Lancet Diabetes Endocrinol
Nice, COVID-19 rapid evidence summary: vitamin D for COVID-19 advice NICE
Panagiotou, Tee, Ihsan, Athar, Marchitelli et al., Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity, Clin Endocrinol,
doi:10.1111/cen.14276
Pham, Rahman, Majidi, Waterhouse, Neale, Acute respiratory tract infection and 25-hydroxyvitamin D concentration: a systematic review and meta-analysis, Int J Environ Res Publ Health
Quesada-Gomez, Entrenas-Castillo, Bouillon, Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: revised Ms SBMB 2020_166, J Steroid Biochem Mol Biol
Raisi-Estabragh, Mccracken, Bethell, Cooper, Cooper et al., Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1,326 cases from the UK Biobank, J Public Health,
doi:10.1093/pubmed/fdaa095
Rao, Manissero, Steele, Pareja, A narrative systematic review of the clinical utility of cycle threshold values in the context of COVID-19, Infect Dis Ther
Rech, Hunsaker, Rodriguez, Deficiency in 25-hydroxyvitamin D and 30-day mortality in patients with severe sepsis and septic shock, Am J Crit Care
Rosa, Malaguarnera, Nicoletti, Malaguarnera, Vitamin D3: a helpful immuno-modulator, Immunology
Tabary, Khanmohammadi, Araghi, Dadkhahfar, Tavangar, Pathologic features of COVID-19: a concise review, Pathol Res Pract
Weir, Thenappan, Bhargava, Chen, Does vitamin D deficiency increase the severity of COVID-19?, Clin Med
Xu, Yang, Chen, Luo, Zhang et al., Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system, Mol Med Rep
Yu, Yan, Wang, Yang, Wang et al., Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients, Clin Infect Dis,
doi:10.1093/cid/ciaa345
Yuki, Fujiogi, Koutsogiannaki, COVID-19 pathophysiology: a review, Clin Immunol
Zhang, Leung, Richers, Liu, Remigio et al., Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1, J Immunol